Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Jian Zhang, MD
CONTACT
Ting Li, MD
CONTACT
Lead
Fudan University
This is a prospective, single-arm, single-center, Simon's two-stage design, phase II clinical trial in triple-negative breast cancer brain metastases patients. Subjects will receive bevacizumab,SHR1316 combined with cisplatin/carboplatin,and will be treated until disease progression, toxicity is intolerable, informed consent is withdrawn, or investigators determine that medication must be discontinued. Drug efficacy and safety data will be collected.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
